Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.
Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.
复制标题
DOI:
10.1038/onc.2009.73
复制
发表时间:
2009-05-21
期刊:
影响因子:
8
通讯作者:
Collins VP
中科院分区:
文献类型:
--
作者:
Jones DT;Kocialkowski S;Liu L;Pearson DM;Ichimura K;Collins VP
Pilocytic astrocytomas (PAs), WHO malignancy grade I, are the most frequently occurring central nervous system tumour in 5-19 year-olds. Recent reports have highlighted the importance of MAPK pathway activation in PAs, particularly through a tandem duplication leading to an oncogenic BRAF fusion gene. Here we report two alternative mechanisms resulting in MAPK activation in PAs. Firstly, in striking similarity to the common BRAF fusion, a tandem duplication at 3p25 was observed, which produces an in-frame oncogenic fusion between SRGAP3 and RAF1. This fusion includes the Raf1 kinase domain, and shows elevated kinase activity when compared with wild-type Raf1. Secondly, a novel 3bp insertion at codon 598 in BRAF mimics the hotspot V600E mutation to produce a transforming, constitutively active BRaf kinase. Whilst these two alterations are not common, they bring the number of cases with an identified ‘hit’ on the Ras/Raf signalling pathway to 36 from our series of 44 (82%), confirming its central importance to the development of pilocytic astrocytomas.
登录
查看更多内容
影响因子:
3.5
作者:
Icking, A;Schilling, K;M端ller-Esterl, W
通讯作者:
M端ller-Esterl, W
影响因子:
1.9
作者:
TOMLINSON, FH;SCHEITHAUER, BW;JACK, CR
通讯作者:
JACK, CR
影响因子:
1.4
作者:
Janzarik, W. G.;Kratz, C. P.;Omran, H.
通讯作者:
Omran, H.
影响因子:
56.9
作者:
BONNER, T;OBRIEN, SJ;LEDER, P
通讯作者:
LEDER, P
影响因子:
1.4
作者:
Dirven, CMF;Mooij, JJA;Molenaar, WM
通讯作者:
Molenaar, WM